secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2021-08-09T23:59:59+00:00
Accession:  0001297184-21-000041
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 1.02, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar refinances existing debt with new $140M credit facility from Capital One, East West
--------------------------------------------------------------------------------

- New $140M credit facility comprises $70M term loan and $70M revolving line, both five-year maturity.
- Proceeds used to repay all amounts owed to former lenders Cathay Bank and East West; certain mortgage debt to East West remains.
- Interest rates: LIBOR plus 1.75%-2.50% or Base Rate plus 0.75%-1.50% based on leverage ratio.
- Covenants: max total net leverage 2.50x, min fixed charge coverage 1.25x, tested quarterly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718421000041/0001297184-21-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718421000041/amph-20210804x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-21-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer